Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

Medtronic

Medtronic, Inc. (), based in suburban Minneapolis, Minnesota, is the world's largest medical technology company and is a Fortune 500 company.

Read More at Wikipedia
Medtronic 4Q Profit Rose 28% On Fewer Charges, Sales Growth

Medtronic Inc.

's (MDT) fiscal fourth-quarter earnings rose 28% as the medical-device maker reported fewer charges and broad revenue growth.Chairman and Chief Executive Omar Ishrak said the revenue growth was broad based across its businesses and geographies and included stong product introductions and growth in emerging markets--where revenue climbed 20% excluding currency fluctuations.However, Medtronic has continued to see challenges in its key cardiac-rhythm and spine segments though the company saw some signs of stabilization in recent quarters. In the latest quarter, revenue from implantable cardioverter defibrillators declined 1% excluding currency impacts, while spinal segment revenue was off by 6%.For the quarter ended April 27, Medtronic reported a profit of $991 million, or 94 cents a share, up from $776 million, or 72 cents a share, a year earlier. Excluding litigation-settlement charges, restructuring charges and other items, earnings were up at 99 cents from 90 cents.Reven...

Read More

  1. Boston Sci Sees Higher Profits, Improving Heart Market

    Boston Scientific Corp.'s (BSX) first-quarter earnings more than doubled as the medical-device maker posted fewer charges, though revenue declined amid a tough marke...

  2. Medtronic Blood Pressure Treatment Safe and Effective In Studies

    DOW JONES NEWSWIRESAn emerging treatment for severe high blood pressure marketed by Medtronic Inc. (MDT) showed safety and effectiveness at one and three years in se...

  3. Medtronic Valve Study Shows Low Mortality, Stroke Rates

    Patients treated with a catheter-delivered heart valve marketed by Medtronic Inc. (MDT) had improvement in valve function and low rates of mortality and stroke at on...

  4. Medtronic Valve Study Shows Higher Mortality Rate At 6 Months

    DOW JONES NEWSWIRESPatients treated with a catheter-delivered heart valve marketed by Medtronic Inc. (MDT) had improvement in valve function but saw higher rates of ...

  5. Bank Bonds Lead Corporate Market Higher

    A range of companies is tapping the U.S. credits markets on signs that investor demand for risky assets is holding up, particularly after the Federal Reserve said 15...

  6. Medtronic Issues Battery Depletion Advisory For Heart Devices

    A small percentage of Medtronic Inc.'s (MDT) heart devices may have problems where battery life depletes faster than expected, the company said in an online advisory...

  7. Medtronic 3Q Profit Rises 1.2%; Narrows Year EPS View

    Medtronic Inc.'s (MDT) fiscal third-quarter earnings rose 1.2%, with the medical device maker benefiting from fewer charges and the impact of divesting its Physio-Co...

  8. As Spine Sales Fall, Medtronic Sees Room for Improvement

    Medtronic (NYSE:MDT) reported slightly higher sales and profit in the third-quarter but continued to struggle with soft demand for its implantable heart defibrillato...

  9. Medtronic Posts Higher Quarterly Net Profit, Sales

    Medtronic Inc. reported net profit of $935 million, or 88 cents a share, for the third quarter ended Jan. 27, up from $924 million, or 86 cents, earned in the same p...

  10. FDA Approves Medtronic Drug-Eluting Heart Stent

    DOW JONES NEWSWIRESThe U.S. Food and Drug Administration approved a new Medtronic Inc. (MDT) heart stent for treatment of coronary artery disease, the company said F...

  11. Market For Heart Devices Won't Get A Jolt Anytime Soon

    Don't expect sales of devices that shock the heart to get a jolt anytime soon.The domestic market for implantable cardioverter defibrillators, or ICDs, slumped an es...

  12. Judge Affirms Rulings Denying Medtronic , NuVasive Motions

    A federal court judge has denied Medtronic Inc.'s (MDT) effort to seek a permanent injunction against spinal-product competitor NuVasive Inc. (NUVA), plus other moti...

  1. Medtronic Q4 Profit Rises

    Medtronic Inc. said on Tuesday that its fiscal fourth-quarter profit roses to $991 million, or 95 cents per share, from $776 million, or 73 cents a share a year ago....

  2. St Jude Defibrillator Lead Performed Worse Than Competitor-Study

    St. Jude Riata leads perform worse than competitor leads in study- Data collected retrospectively from seven centers- St. Jude stopped selling Riata in 2010NEW YORK ...

  3. Medtronic ICD Study Of Extended Detection Time Meets Endpoint

    Medtronic Inc. (MDT) said a clinical trial of its cardiac devices showed detection time in the devices can be extended without risking the health of patients, findin...

  4. St Jude Defibrillator Lead Performed Worse Than Competitor Lead -Study

    St. Jude Medical Inc.'s (STJ) Riata defibrillator leads performed significantly worse than Medtronic Inc.'s (MDT) Quattro leads, according to results from a multicen...

  5. FDA Panel Backs Cameron Health Heart Defibrillator

    A federal advisory panel backed a new type of implantable heart defibrillator being developed by Cameron Health Inc., saying it represents an additional treatment op...

  6. FDA Sees Higher Infection Rate In Study Of New Type Of Heart Defibrillator

    The Food and Drug Administration Monday said patients receiving a new type of heart defibrillator being developed by Cameron Health Inc. had higher rates of infectio...

  7. Boston Scientific Sees Higher Profits, Improving Heart Market

    Boston Scientific Corp.'s (BSX) first-quarter earnings more than doubled as the medical-device maker posted fewer charges and suggested that declines in its heart rh...

‹ Prev12345Next ›
Freebase CC-BY
Source: Medtronic on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL